| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.40▼ | 1.38▲ | 1.36▲ | 1.38▼ | 1.43▼ |
| MA10 | 1.40▼ | 1.36▲ | 1.36▲ | 1.40▼ | 1.61▼ |
| MA20 | 1.39▼ | 1.36▲ | 1.37▲ | 1.43▼ | 1.57▼ |
| MA50 | 1.36▲ | 1.38▲ | 1.41▼ | 1.63▼ | 1.51▼ |
| MA100 | 1.36▲ | 1.41▼ | 1.41▼ | 1.59▼ | 1.47▼ |
| MA200 | 1.37▲ | 1.41▼ | 1.52▼ | 1.55▼ | 2.06▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | 0.007▲ | 0.003▲ | 0.003▲ | -0.041▼ |
| RSI | 48.147▼ | 54.458▲ | 50.842▲ | 37.184▼ | 39.886▼ |
| STOCH | 43.333 | 61.251 | 75.069 | 25.976 | 17.647▼ |
| WILL %R | -100.000▼ | -44.444 | -22.222▲ | -54.839 | -82.390▼ |
| CCI | -131.702▼ | 134.247▲ | 115.528▲ | -68.167 | -129.571▼ |
|
Thursday, May 01, 2025 09:43 AM
Despite strength in OPKO Health's revenues from the transfer of intellectual property, the company reports an overall soft first-quarter 2025 performance.
|
|
Thursday, May 01, 2025 12:17 AM
OPKO Health Inc (OPK) navigates a challenging quarter with strategic asset sales, cost-saving measures, and promising developments in its pharmaceutical pipeline.
|
|
Wednesday, April 30, 2025 04:53 PM
OPKO Health Q1 2025 earnings call highlights strategic moves, including the Labcorp sale and pharmaceutical advancements.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/05/25 | 1.345 | 1.42 | 1.345 | 1.38 | 1,035,245 |
| 01/05/25 | 1.31 | 1.38 | 1.24 | 1.35 | 4,470,022 |
| 30/04/25 | 1.39 | 1.40 | 1.36 | 1.38 | 2,581,831 |
| 29/04/25 | 1.38 | 1.415 | 1.355 | 1.39 | 2,674,932 |
| 28/04/25 | 1.41 | 1.42 | 1.39 | 1.41 | 2,031,862 |
| 25/04/25 | 1.44 | 1.46 | 1.40 | 1.41 | 3,299,592 |
| 24/04/25 | 1.48 | 1.48 | 1.43 | 1.46 | 2,304,008 |
| 23/04/25 | 1.50 | 1.55 | 1.44 | 1.47 | 2,679,615 |
| 22/04/25 | 1.40 | 1.45 | 1.38 | 1.43 | 2,969,944 |
| 21/04/25 | 1.41 | 1.42 | 1.37 | 1.37 | 1,916,904 |
|
|
||||
|
|
||||
|
|